< Back to latest news & events

Event

Arab Health 2019 – Dubai

January 2019

Event date: 28th January 2019

HGF will be exhibiting at Arab Health 28th – 31st Jan 2019 in Dubai, Arab Health is the largest gathering of healthcare and trade professionals in the MENA (Middle East, North African) region.

Visit the HGF stand – Hall 7 stand H11

HGF Partners Vanessa Stainthorpe and Kieran Killough will be attending Arab Health 28th – 31st Jan 2019. They will be available throughout the conference to offer their expert advice on how you can protect, exploit and defend your intellectual property assets.

To arrange a meeting please email Anita O’Neil at aoneil@hgf.com advising of your preferred day, time and location.

Arab Health 2019 takes place at Dubai World Trade Centre from 28th – 31st Jan 2019 and is expected to welcome more than 4,150 exhibiting companies and over 84,500 attendess from 160+ countries.

For more information on Arab Health visit www.arabhealthonline.com.

Attendees

Kieran
Killough

Partner & Patent Attorney

Vanessa
Stainthorpe

Partner & Patent Attorney

Latest updates

The FoodTech Series #1 | Multi-parameter claims, examples outside the scope of the claims: when improvement occurs and evidence becomes easier to demonstrate

            The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they ruled on an opposition …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second installment …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details
See all updates